邦妮邦德2014-09-28 19:32
$Ariad Pharmaceuticals(ARIA)$
1292P - ALK inhibitor AP26113 in patients with advanced malignancies, including ALK+ non-small cell lung cancer (NSCLC): Updated efficacy and safety dataAim
AP26113 is an investigational orally-active tyrosine kinase inhibitor with preclin...查看全文
邦妮邦德2014-09-21 00:16
$Ariad Pharmaceuticals(ARIA)$
网页链接
Activist investor Alex Denner is about to get another ally on Ariad Pharmaceuticals' (Aria) board of directors, which ...查看全文
$Ariad制药(ARIA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-04-07 AccNo: 0001085146-17-000907 Size: 27 KB 网页链接
$Ariad制药(ARIA)$ CT ORDER - Confidential treatment order Filed: 2017-02-27 AccNo: 9999999997-17-001121 Size: 10 KB 网页链接
$Ariad制药(ARIA)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2017-02-27 AccNo: 0001193125-17-057984 Size: 10 KB 网页链接
$Ariad制药(ARIA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-02-21 AccNo: 0000899140-17-000284 Size: 89 KB 网页链接
$Ariad制药(ARIA)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-02-16 AccNo: 0001193125-17-046797 Size: 29 KB 网页链接
$Ariad制药(ARIA)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-02-16 AccNo: 0001193125-17-046793 Size: 29 KB 网页链接
$Ariad制药(ARIA)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-02-16 AccNo: 0001193125-17-046782 Size: 29 KB 网页链接
$Ariad制药(ARIA)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-02-16 AccNo: 0001193125-17-046777 Size: 29 KB 网页链接
$Ariad制药(ARIA)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-02-16 AccNo: 0001193125-17-046773 Size: 29 KB 网页链接
$Ariad制药(ARIA)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2017-02-16 AccNo: 0001193125-17-046763 Size: 29 KB 网页链接